Novo Nordisk plots commercial relaunch for Wegovy as supplies are expected to return
After tapping Queen Latifah for an unbranded campaign to help change the narrative around weight loss last year, Novo Nordisk’s direct-to-consumer plans for its new obesity med Wegovy didn’t go quite as planned. Now, the company is planning a commercial relaunch.
Novo halted Wegovy promotions back in March as the company grappled with supply issues. The company said on its Q3 call on Wednesday that all dose strengths should finally be available by the end of this year — and with that, a “broad commercial re-launch is expected to commence next year,” a spokesperson told Endpoints News via email.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
